UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2016-10, Vol.375 (16), p.1532-1543

2016

Volltextzugriff (PDF)

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Journal of bone and mineral metabolism, 2020-05, Vol.38 (3), p.310-315

2020

Volltextzugriff (PDF)

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

Journal of bone and mineral research, 2019-03, Vol.34 (3), p.419-428

2019

Volltextzugriff (PDF)

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Osteoporosis international, 2022-06, Vol.33 (6), p.1243-1256

2022

Volltextzugriff (PDF)

Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial

Journal of bone and mineral metabolism, 2021-03, Vol.39 (2), p.278-288

2021

Volltextzugriff (PDF)

Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease

Journal of bone and mineral metabolism, 2022-07, Vol.40 (4), p.677-687

2022

Volltextzugriff (PDF)

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension

Archives of osteoporosis, 2019-06, Vol.14 (1), p.59-59, Article 59

2019

Volltextzugriff (PDF)

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

The New England journal of medicine, 2003-04, Vol.348 (17), p.1656-1663

2003

Volltextzugriff (PDF)

Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Journal of bone and mineral metabolism, 2020-07, Vol.38 (4), p.605-605

2020

Volltextzugriff (PDF)

Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis

The journal of clinical endocrinology and metabolism, 2009-11, Vol.94 (11), p.4267-4274

2009

Volltextzugriff (PDF)

Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance

Journal of bone and mineral metabolism, 2012-11, Vol.30 (6), p.674-682

2012

Volltextzugriff (PDF)

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

JBMR plus, 2019-10, Vol.3 (10), p.e10211-n/a

2019

Volltextzugriff (PDF)

Distinct Anabolic Response of Osteoblast to Low‐Intensity Pulsed Ultrasound

Journal of bone and mineral research, 2003-02, Vol.18 (2), p.360-369

2003

Volltextzugriff (PDF)

Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36

Journal of bone and mineral metabolism, 2011-09, Vol.29 (5), p.588-597

2011

Volltextzugriff (PDF)

Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance

Journal of bone and mineral metabolism, 2009-03, Vol.27 (2), p.234-239

2009

Volltextzugriff (PDF)

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

Journal of bone and mineral metabolism, 2008-11, Vol.26 (6), p.624-634

2008

Volltextzugriff (PDF)

Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in Japan

Bone (New York, N.Y.), 2011-09, Vol.49 (3), p.520-525

2011

Volltextzugriff (PDF)

Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia

Journal of bone and mineral metabolism, 2012-01, Vol.30 (1), p.93-99

2012

Volltextzugriff (PDF)

Effect of age on body sway assessed by computerized posturography

Journal of bone and mineral metabolism, 2005-03, Vol.23 (2), p.152-156

2005

Volltextzugriff (PDF)

Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism

European journal of endocrinology, 2006-01, Vol.154 (1), p.93-99

2006

Volltextzugriff (PDF)

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

The journal of clinical endocrinology and metabolism, 2018-09, Vol.103 (9), p.3183-3193

2018

Volltextzugriff (PDF)

Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study

Journal of bone and mineral metabolism, 2024-01, Vol.42 (1), p.77-89

2024

Volltextzugriff (PDF)

Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study

Bone (New York, N.Y.), 2017-10, Vol.103, p.209-215

2017

Volltextzugriff (PDF)

Relationship of pharmacokinetics, changes of bone turnover markers and BMD/fractures efficacy during treatment with anabolic agents;Teriparatide daily and once weekly subcutaneous injections.

Clinical calcium, 2016, Vol.26 (11), p.1583

Miyauchi, Akimitsu

2016

Volltextzugriff (PDF)

Prompt Analgesic Effect of Antihistaminic Diphenhydramine Ointment on Bone-Joint-Muscle Pain as Assessed by Skin Impedance

Pharmacology, 2013-01, Vol.92 (3-4), p.158-166

2013

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(106)
Buchkapitel
(1)

Sprache

Englisch
(100)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(64)
Humans
(55)
Biological And Medical Sciences
(51)
Endocrinology & Metabolism
(40)
Female
(40)
Medical Sciences
(38)
Male
(27)
Aged
(26)
Animals
(26)
Medicine, Research & Experimental
(26)
Middle Aged
(26)
Osteoporosis
(26)
Research & Experimental Medicine
(26)
Fundamental And Applied Biological Sciences. Psychology
(20)
Diseases Of The Osteoarticular System
(19)
Bone Density
(18)
Orthopedics
(18)
Bone Mineral Density
(16)
Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial

Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis

Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

Distinct Anabolic Response of Osteoblast to Low‐Intensity Pulsed Ultrasound

Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36

Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in Japan

Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia

Effect of age on body sway assessed by computerized posturography

Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study

Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study

Relationship of pharmacokinetics, changes of bone turnover markers and BMD/fractures efficacy during treatment with anabolic agents;Teriparatide daily and once weekly subcutaneous injections.

Prompt Analgesic Effect of Antihistaminic Diphenhydramine Ointment on Bone-Joint-Muscle Pain as Assessed by Skin Impedance

Suchergebnisse filtern